Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Read more about Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.
Low-risk Prostate Cancer: Identification, Management, and Outcomes. Read more about Low-risk Prostate Cancer: Identification, Management, and Outcomes.
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Read more about Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer. Read more about Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Read more about Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes. Read more about Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study. Read more about Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
Magnetic Resonance Imaging-targeted Prostate Biopsies: Is the Right Technique the Right Question? Read more about Magnetic Resonance Imaging-targeted Prostate Biopsies: Is the Right Technique the Right Question?
Re: 10-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. Read more about Re: 10-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study. Read more about Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
